<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01637025</url>
  </required_header>
  <id_info>
    <org_study_id>621101</org_study_id>
    <nct_id>NCT01637025</nct_id>
  </id_info>
  <brief_title>Oxidized Cellulose hEmostAsis evaluatioN</brief_title>
  <acronym>OCEAN</acronym>
  <official_title>A Prospective, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of Traumastem as an Adjunct to Hemostasis for Tissue Bleeding in Open Cardiac, Intra-abdominal (Including Retroperitoneal) and Pelvic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Innovations GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of Traumastem to help
      stop bleeding in participants undergoing open cardiac, intra-abdominal (including
      retroperitoneal) and pelvic surgery as compared to Surgicel® Original (Surgicel; in some
      countries marketed as Tabotamp®)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of adverse events (AEs)/ adverse device effects (ADEs)</measure>
    <time_frame>≤30 ± 5 days/ end-of-study visit after device application</time_frame>
    <description>Occurrence of adverse events (AEs)/ adverse device effects (ADEs) up to 30 ± 5 days/ end-of-study visit after device application.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">111</enrollment>
  <condition>Intra-operative Bleeding</condition>
  <arm_group>
    <arm_group_label>Traumastem - oxidized cellulose strip</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgicel® Original - oxidized regenerated cellulose strip</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxidized cellulose strip</intervention_name>
    <description>Single use, intra-operative application to the target bleeding site</description>
    <arm_group_label>Traumastem - oxidized cellulose strip</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxidized regenerated cellulose strip</intervention_name>
    <description>A substance used to promote hemostasis (stops bleeding) based on oxidized regenerated cellulose</description>
    <arm_group_label>Surgicel® Original - oxidized regenerated cellulose strip</arm_group_label>
    <other_name>Tabotamp®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA AT SCREENING:

          1. Participants and/or legal representative has/have provided signed informed consent. An
             assent form should be signed by Participants less than 18 years of age, if possible;

          2. Participants undergoing planned (non-emergency) open cardiac, intra-abdominal
             (including retroperitoneal) and pelvic surgery;

          3. Participants of childbearing potential present with a negative serum pregnancy test,
             and agree to employ adequate birth control measures for the duration of the study.
             Acceptable contraception methods are restricted to abstinence, barrier contraceptives,
             intrauterine contraceptive devices or licensed hormonal products;

          4. Participants are willing and able to comply with the requirements of the clinical
             investigation plan (CIP).

             INCLUSION CRITERIA INTRA-OPERATIVE:

          5. Soft tissue, vascular/anastomotic or parenchymal bleeding is present after primary
             surgical hemostasis has been achieved. The TBS is defined as intra-operative bleeding
             where conventional methods for achieving hemostasis are ineffective (based on the type
             of tissue) or impractical (based on the location) and where treatment with topical
             hemostatic adjuncts such as Traumastem is deemed appropriate for use.

        EXCLUSION CRITERIA:

          1. Emergency surgery;

          2. Transplantation surgery;

          3. Minimally invasive surgery;

          4. Neurological and ophthalmological surgery;

          5. Major arterial bleeding at the target bleeding site (TBS);

          6. Major intra-operative complications that require resuscitation or deviation from the
             planned surgical procedure;

          7. Severe local inflammation at the operating field;

          8. Any prior radiation therapy to the operating field;

          9. Known severe congenital or acquired immunodeficiency (eg, human immunodeficiency virus
             [HIV] infection or long-term [&gt; 3 months] treatment with immunosuppressive drugs);

         10. Known hypersensitivity to components of the investigational device;

         11. Participant is pregnant or lactating at the time of enrollment or becomes pregnant
             prior to the planned surgery. If the participant becomes pregnant during the 30 days
             following treatment exposure, attempts will be made to follow her through completion
             of the pregnancy. The investigator will record a narrative description of the course
             of the pregnancy and its outcome;

         12. Participant has a clinically significant medical, psychiatric, or cognitive illness,
             or drug/alcohol abuse that, in the opinion of the investigator, would affect
             participant's safety or compliance;

         13. Participant has participated in another clinical study involving an investigational
             device/drug within 30 days prior to enrollment or is scheduled to participate in
             another clinical study involving an investigational device/drug during the course of
             this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edith Hantak, DVM</last_name>
    <role>Study Director</role>
    <affiliation>Baxter Innovations GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chirurgicke oddeleni Nemocnice Liberec</name>
      <address>
        <city>Liberec</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiochirurgicke oddeleni FN Plzen</name>
      <address>
        <city>Plzen - Lochotin</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgicka klinika FN KV</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgicka klinika UVN</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgicke oddeleni Fakultni nemocnice Na Bulovce</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiochirurgicka klinika FN KV</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika kardiovaskularni chirurgie IKEM</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Allgemein-, Visceral- und Transplantationschirurgie Charité Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Allgemein-, Visceral-, Gefäß- und Thoraxchirurguie Charité Universitätsmedizin Berlin - Campus Mitte</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemein- und Viszeralchirurgie Johann Wolfgang Goethe Universitätsklinikum</name>
      <address>
        <city>Frankfurt am Main</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Allgemeine Chirurgie, Viszeral-, Gefäß- und Kinderchirurgie Universitätsklinikum des Saarlandes</name>
      <address>
        <city>Homburg/Saar</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Allgemein- und Viszeralchirurgie Klinikum Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Allgemein- und Abdominalchirurgie Universitätsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I. Surgery Clinic Semmelweis Egyetem Általános Orvostudományi Kar</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of General Surgery Petz Aladár Megyei Oktató Kórház</name>
      <address>
        <city>Gyor</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynaecology and Obstetrics Petz Aldor Country Teaching Hospital</name>
      <address>
        <city>Gyor</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of General Surgery Békés Megyei Képviselotestület Pándy Kálmán Kórház</name>
      <address>
        <city>Gyula</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgery Albert Szentgyörgyi Clinical Center</name>
      <address>
        <city>Szeged</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of General Surgery Békés Megyei Képviselotestület Pándy Kálmán Kórház</name>
      <address>
        <city>Szekesfehervar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Chirurgii Naczyniowej, Ogólnej i Angiologii, Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM,</name>
      <address>
        <city>Szczecin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Chirurgii Ogólnej i Translantacyjnej, Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM,</name>
      <address>
        <city>Szczecin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Chirurgii Naczyniowej, Instytut Hematologii I Transfuzjologii,</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Chirurgii Ogólnej, Gastroenterologicznej i Endokrynologicznej, Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wrocławiu</name>
      <address>
        <city>Wrocław</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niepubliczny Specjalistyczny Zakład Opieki Zdrowotnej &quot;MEDICUS&quot;,</name>
      <address>
        <city>Środa Wielkopolska</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2012</study_first_submitted>
  <study_first_submitted_qc>July 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2012</study_first_posted>
  <last_update_submitted>January 23, 2013</last_update_submitted>
  <last_update_submitted_qc>January 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Blood Loss, Surgical</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
    <mesh_term>Cellulose, Oxidized</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

